9h
Pharmaceutical Technology on MSNUSPTO allows patents for Remedy’s large hemispheric infarction drugThe US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara to treat large ...
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
The National Institutes of Health Stroke Scale (NIHSS) is a well-validated, reliable scoring system for use specifically with stroke patients (Goldstein, Bertels, & Davis, 1989; Lyden et al., ...
2d
News-Medical.Net on MSNStudy shows potential of uric acid as add-on therapy for strokeIn a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard ...
Hosted on MSN2mon
USACS partners with Penn Medicine for stroke diagnosisUS Acute Care Solutions (USACS) has partnered with the University of Pennsylvania Health System (Penn Medicine) to implement the ‘dizziNIHSS’ initiative across the latter’s Philadelphia ...
Secondary outcomes included performance on a gait speed test, Barthel Index (BI), NIH Stroke Scale score (NIHSS), Fluid-attenuated inversion recovery (FLAIR) MRI, resting state fMRI and ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
The National Institutes of Health Stroke Scale (NIHSS) is accepted as the definitive clinical examination to assess stroke severity. This project examined barriers to implementation and NIHSS use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results